A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties
Rajshekhar Chakraborty(Columbia University Irving Medical Center), Shahrukh K. Hashmi(Mayo Clinic), Mohamad Mohty(Sorbonne Université), Bipin N. Savani(Vanderbilt University Medical Center), Mark R. Litzow(Dana-Farber Cancer Institute)
Cited by 24
Related Papers
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
|Nature Medicine|2023|534
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434